Heidi A Hamann1, Ju-Whei Lee, Joan H Schiller, Leora Horn, Lynne I Wagner, Victor Tsu-Shih Chang, Michael J Fisch. 1. *Harold C. Simmons Cancer Center, Departments of Psychiatry and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas; †Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts; ‡Harold C. Simmons Cancer Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; §Department of Medical Oncology, Vanderbilt University, Nashville, Tennessee; ‖Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois; ¶VA New Jersey Health Care System, East Orange, New Jersey, Rutgers - New Jersey Medical School, Newark, New Jersey; and #Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
INTRODUCTION: Despite recent therapeutic advances, lung cancer is a difficult disease to manage. This study assessed clinicians' perceptions of care difficulty, quality of life (QOL), and symptom reports for their lung cancer patients compared with their patients with breast, prostate, and colon cancer. METHODS: This report focused on secondary analyses from the Eastern Cooperative Oncology Group (ECOG) Symptom Outcomes and Practice Patterns (SOAPP) study (E2Z02); outcome measures included clinician ratings of 3106 solid tumor patients. Univariate analyses focused on patterns of disease-specific perceptions; multivariable analyses examined whether disease-specific differences persisted after covariate inclusion. RESULTS: In univariate comparisons, clinicians rated lung cancer patients as more difficult to treat than other solid tumor patients, with poorer QOL and higher symptom reports. After covariates were adjusted, the odds of clinicians perceiving lower QOL for their lung cancer patients were 3.6 times larger than for patients with other solid tumors (odds ratio = 3.6 [95% confidence interval, 2.0-6.6]; p < 0.0001). In addition, the odds of clinicians perceiving weight difficulties for their lung cancer patients were 3.2 times larger (odds ratio = 3.2 [95% confidence interval, 1.7-6.0]; p = 0.0004). No other outcome showed significant differences between lung versus other cancers in multivariable models. CONCLUSION: Clinicians were more pessimistic about the well-being of their lung cancer patients compared with patients with other solid tumors. Differences remained for clinician perceptions of patient QOL and weight difficulty, even after controlling for such variables as stage, performance status, and patient-reported outcomes. These continuing disparities suggest possible perception bias. More research is needed to confirm this disparity and explore the underpinnings.
INTRODUCTION: Despite recent therapeutic advances, lung cancer is a difficult disease to manage. This study assessed clinicians' perceptions of care difficulty, quality of life (QOL), and symptom reports for their lung cancerpatients compared with their patients with breast, prostate, and colon cancer. METHODS: This report focused on secondary analyses from the Eastern Cooperative Oncology Group (ECOG) Symptom Outcomes and Practice Patterns (SOAPP) study (E2Z02); outcome measures included clinician ratings of 3106 solid tumorpatients. Univariate analyses focused on patterns of disease-specific perceptions; multivariable analyses examined whether disease-specific differences persisted after covariate inclusion. RESULTS: In univariate comparisons, clinicians rated lung cancerpatients as more difficult to treat than other solid tumorpatients, with poorer QOL and higher symptom reports. After covariates were adjusted, the odds of clinicians perceiving lower QOL for their lung cancerpatients were 3.6 times larger than for patients with other solid tumors (odds ratio = 3.6 [95% confidence interval, 2.0-6.6]; p < 0.0001). In addition, the odds of clinicians perceiving weight difficulties for their lung cancerpatients were 3.2 times larger (odds ratio = 3.2 [95% confidence interval, 1.7-6.0]; p = 0.0004). No other outcome showed significant differences between lung versus other cancers in multivariable models. CONCLUSION: Clinicians were more pessimistic about the well-being of their lung cancerpatients compared with patients with other solid tumors. Differences remained for clinician perceptions of patient QOL and weight difficulty, even after controlling for such variables as stage, performance status, and patient-reported outcomes. These continuing disparities suggest possible perception bias. More research is needed to confirm this disparity and explore the underpinnings.
Authors: Rafael Rosell; Enric Carcereny; Radj Gervais; Alain Vergnenegre; Bartomeu Massuti; Enriqueta Felip; Ramon Palmero; Ramon Garcia-Gomez; Cinta Pallares; Jose Miguel Sanchez; Rut Porta; Manuel Cobo; Pilar Garrido; Flavia Longo; Teresa Moran; Amelia Insa; Filippo De Marinis; Romain Corre; Isabel Bover; Alfonso Illiano; Eric Dansin; Javier de Castro; Michele Milella; Noemi Reguart; Giuseppe Altavilla; Ulpiano Jimenez; Mariano Provencio; Miguel Angel Moreno; Josefa Terrasa; Jose Muñoz-Langa; Javier Valdivia; Dolores Isla; Manuel Domine; Olivier Molinier; Julien Mazieres; Nathalie Baize; Rosario Garcia-Campelo; Gilles Robinet; Delvys Rodriguez-Abreu; Guillermo Lopez-Vivanco; Vittorio Gebbia; Lioba Ferrera-Delgado; Pierre Bombaron; Reyes Bernabe; Alessandra Bearz; Angel Artal; Enrico Cortesi; Christian Rolfo; Maria Sanchez-Ronco; Ana Drozdowskyj; Cristina Queralt; Itziar de Aguirre; Jose Luis Ramirez; Jose Javier Sanchez; Miguel Angel Molina; Miquel Taron; Luis Paz-Ares Journal: Lancet Oncol Date: 2012-01-26 Impact factor: 41.316
Authors: Heidi A Hamann; Jamie S Ostroff; Emily G Marks; David E Gerber; Joan H Schiller; Simon J Craddock Lee Journal: Psychooncology Date: 2013-10-03 Impact factor: 3.894
Authors: Carrie N Klabunde; Nancy L Keating; Arnold L Potosky; Anita Ambs; Yulei He; Mark C Hornbrook; Patricia A Ganz Journal: J Natl Cancer Inst Date: 2011-02-11 Impact factor: 13.506
Authors: Timothy R Wassenaar; Jens C Eickhoff; Daniel R Jarzemsky; Stevens S Smith; Marilyn L Larson; Joan H Schiller Journal: J Thorac Oncol Date: 2007-08 Impact factor: 15.609
Authors: Heidi A Hamann; Jamie S Ostroff; Emily G Marks; David E Gerber; Joan H Schiller; Simon J Craddock Lee Journal: Psychooncology Date: 2013-10-03 Impact factor: 3.894
Authors: Heidi A Hamann; Elizabeth S Ver Hoeve; Lisa Carter-Harris; Jamie L Studts; Jamie S Ostroff Journal: J Thorac Oncol Date: 2018-05-23 Impact factor: 15.609
Authors: Leslie J Blackhall; Paul Read; George Stukenborg; Patrick Dillon; Joshua Barclay; Andrew Romano; James Harrison Journal: J Palliat Med Date: 2015-12-01 Impact factor: 2.947
Authors: Timothy J Williamson; Alyssa K Choi; Julie C Kim; Edward B Garon; Jenessa R Shapiro; Michael R Irwin; Jonathan W Goldman; Krikor Bornyazan; James M Carroll; Annette L Stanton Journal: J Thorac Oncol Date: 2018-07-05 Impact factor: 15.609